SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lee Jeong James

(Last)

(First)

(Middle)

10900 WILSHIRE BLVD. SUITE 600

(Street)

LOS ANGELES

90024

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/16/2024

3. Issuer Name and Ticker or Trading Symbol
ChromaDex Corp. [ CDXC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Options (right to buy)	07/06/2016⁽¹⁾	07/05/2025	Common Stock	8,334	$3.66	D
Employee Stock Options (right to buy)	07/14/2017⁽²⁾	08/14/2026	Common Stock	17,000	$4.04	D
Employee Stock Options (right to buy)	09/29/2018⁽³⁾	10/23/2027	Common Stock	50,000	$3.97	D
Employee Stock Options (right to buy)	02/21/2020⁽⁴⁾	02/20/2029	Common Stock	32,386	$3.84	D
Employee Stock Options (right to buy)	02/25/2021⁽⁵⁾	02/24/2030	Common Stock	30,800	$3.27	D
Employee Stock Options (right to buy)	03/15/2022⁽⁶⁾	03/14/2031	Common Stock	11,000	$11.83	D
Employee Stock Options (right to buy)	02/17/2023⁽⁷⁾	02/16/2032	Common Stock	42,219	$2.67	D
Employee Stock Options (right to buy)	02/15/2024⁽⁸⁾	02/14/2033	Common Stock	58,097	$1.82	D
Employee Stock Options (right to buy)	02/22/2025⁽⁹⁾	02/21/2034	Common Stock	82,734	$1.52	D

Explanation of Responses:

1. One-fourth of the shares subject to the option vested on July 6, 2016 and the remaining shares subject to the option have vested in a series of 36 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

2. One-fourth of the shares subject to the option vested on July 14, 2017 and the remaining shares subject to the option have vested in a series of 36 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

3. One-third of the shares subject to the option vested on September 29, 2018 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

4. One-third of the shares subject to the option vested on February 21, 2020 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

5. One-third of the shares subject to the option vested on February 25, 2021 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

6. One-third of the shares subject to the option vested on March 15, 2022 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.

7. One-third of the shares subject to the option vested on February 17, 2023 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.

8. One-third of the shares subject to the option vested on February 15, 2024 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.

9. One-third of the shares subject to the option shall vest on February 22, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter.

Remarks:

	/s/ Jeong James Lee	07/26/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 3 filed by new insider Lee Jeong James